Australia markets close in 6 hours 4 minutes

Antisense Therapeutics Limited (ANP.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0970-0.0080 (-7.62%)
As of 03:54PM AEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2021
30/06/2020
30/06/2019
Operating expenses
Research development
5,344
4,913
1,899
1,091
Selling general and administrative
4,090
3,556
4,456
2,349
Total operating expenses
9,619
8,683
6,666
3,583
Operating income or loss
-9,619
-8,683
-6,666
-3,583
Total other income/expenses net
627.251
629.195
740.099
572.469
Income before tax
-9,000
-8,061
-5,908
-2,944
Income tax expense
0
0
0
0
Income from continuing operations
-9,000
-8,061
-5,908
-2,944
Net income
-9,000
-8,061
-5,908
-2,944
Net income available to common shareholders
-9,000
-8,061
-5,908
-2,944
Basic EPS
-
-0.01
-0.01
-0.01
Diluted EPS
-
-0.01
-0.01
-0.01
Basic average shares
-
540,980
455,834
386,098
Diluted average shares
-
540,980
455,834
386,098
EBITDA
-
-8,580
-6,559
-3,578